ELOVL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.463500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.797700E-02
Normal-vs-Stage2
1.742210E-02
Normal-vs-Stage3
3.713600E-02
Normal-vs-Stage4
1.556220E-01
Stage1-vs-Stage2
5.393000E-01
Stage1-vs-Stage3
5.002200E-01
Stage1-vs-Stage4
4.288400E-01
Stage2-vs-Stage3
2.534400E-01
Stage2-vs-Stage4
7.625400E-01
Stage3-vs-Stage4
1.294010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.821700E-02
Normal-vs-AfricanAmerican
1.447960E-01
Normal-vs-Asian
4.376500E-03
Caucasian-vs-AfricanAmerican
8.848200E-01
Caucasian-vs-Asian
1.357780E-01
AfricanAmerican-vs-Asian
2.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.188500E-02
Normal-vs-Female
3.823700E-02
Male-vs-Female
5.438000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.081800E-02
Normal-vs-Age(41-60Yrs)
6.750200E-02
Normal-vs-Age(61-80Yrs)
2.239800E-02
Normal-vs-Age(81-100Yrs)
1.165690E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.479990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.651400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.418600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.210140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.985930E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.576900E-03
Normal-vs-Daily Drinker
3.811000E-04
Normal-vs-Weekly Drinker
2.631900E-02
Normal-vs-Occasional Drinker
3.314600E-01
Normal-vs-Social Drinker
8.967700E-02
Non Drinker-vs-Daily Drinker
2.117600E-01
Non Drinker-vs-Weekly Drinker
7.093600E-01
Non Drinker-vs-Occasional Drinker
1.199390E-01
Non Drinker-vs-Social Drinker
1.727400E-01
Daily Drinker-vs-Weekly Drinker
1.500240E-01
Daily Drinker-vs-Occasional Drinker
2.900300E-02
Daily Drinker-vs-Social Drinker
1.883810E-02
Weekly Drinker-vs-Occasional Drinker
2.285200E-01
Weekly Drinker-vs-Social Drinker
4.154400E-01
Occasional Drinker-vs-Social Drinker
6.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.550000E-01
Normal-vs-Grade 2
4.093800E-01
Normal-vs-Grade 3
8.171800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.337600E-01
Grade 1-vs-Grade 3
4.255000E-01
Grade 1-vs-Grade 4
5.550000E-01
Grade 2-vs-Grade 3
2.932400E-01
Grade 2-vs-Grade 4
4.093800E-01
Grade 3-vs-Grade 4
8.171800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.342100E-02
Normal-vs-NonDiabetic
1.993790E-02
Diabetic-vs-NonDiabetic
9.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.201600E-03
Normal-vs-NoPancreatitis
2.843700E-02
Pancreatitis-vs-NoPancreatitis
2.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.861600E-02
Normal-vs-N1
1.919920E-02
N0-vs-N1
8.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.218500E-03
Normal-vs-TP53-NonMutant
4.295800E-02
TP53-Mutant-vs-TP53-NonMutant
2.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
